Clinical Trial Update: Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a combination of epigenetic therapy and sensitising therapy in acute myeloid leukemia, myelodysplastic syndromes, and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Epigenetic and Sensitising Therapy (combination)

Snippet

Sponsor: Clinical Hub for Interventional Research (CHOIR) | Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | Status: RECRUITING